These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18681186)

  • 21. [Coinfection with HIV and HCV--epidemiologic, diagnostic, clinical and therapeutic implications].
    Jabłonowska E
    Przegl Epidemiol; 2004; 58(4):621-8. PubMed ID: 15810503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop.
    Carosi G; Puoti M; Antonucci G; De Luca A; Maserati R; Torti C; Bonfanti P; Bonora S; Bruno R; Gaeta GB; Antinori A; Monforte Ad; Orani A; Sagnelli E; Cargnel A; Cauda R; Mazzotta F; Pastore G; Suter F; Vullo V; ;
    AIDS Rev; 2005; 7(3):161-7. PubMed ID: 16302464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic hepatitis C in HIV-infected patients. Unfavorable interaction of HIV and HCV infection].
    Mauss S
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():60-2. PubMed ID: 10863316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obstacles to successful HCV treatment in substance addicted patients.
    Cooper CL
    J Addict Dis; 2008; 27(2):61-8. PubMed ID: 18681192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of chronic hepatitis C in active drug users.
    Davis GL; Rodrigue JR
    N Engl J Med; 2001 Jul; 345(3):215-7. PubMed ID: 11463020
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of hepatitis C viral infections in substance abusers.
    Robaeys G; Buntinx F
    Acta Gastroenterol Belg; 2005; 68(1):55-67. PubMed ID: 15832589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis C in drug addicts: access and treatment compliance].
    Sarmento E Castro R; Valente C; Ramos JP; Almeida JR; Marinho RT; Branco T; Andrade S; Macedo A
    Acta Med Port; 2011 Dec; 24 Suppl 2():483-92. PubMed ID: 22849938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study.
    Judd A; Hickman M; Jones S; McDonald T; Parry JV; Stimson GV; Hall AJ
    BMJ; 2005 Jan; 330(7481):24-5. PubMed ID: 15533854
    [No Abstract]   [Full Text] [Related]  

  • 30. Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.
    Bonner JE; Barritt AS; Fried MW; Evon DM
    Dig Dis Sci; 2012 Jun; 57(6):1469-74. PubMed ID: 22484494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Then and now … HIV consultation psychiatry update.
    Goforth HW; Bader M; Fernandez F
    Adv Psychosom Med; 2015; 34():49-60. PubMed ID: 25832513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV.
    El-Khatib Z; Richter M
    S Afr Med J; 2009 Jun; 99(6):412, 414. PubMed ID: 19739316
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of human immunodeficiency virus and hepatitis B virus infections.
    Zoulim F; Bailly F; Johnson M; Kessler C
    Haemophilia; 2012 Jul; 18 Suppl 4():34-7. PubMed ID: 22726080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management.
    Loftis JM; Matthews AM; Hauser P
    Drugs; 2006; 66(2):155-74. PubMed ID: 16451091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse.
    Khalsa JH; Treisman G; McCance-Katz E; Tedaldi E
    Subst Abus; 2008; 29(3):5-16. PubMed ID: 19042203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami.
    Baum MK; Jayaweera DT; Duan R; Sales S; Lai S; Rafie C; Regev A; Page JB; Berkman R; Campa A
    J Addict Dis; 2008; 27(2):37-48. PubMed ID: 18681190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Striving for individual therapy].
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():40-1. PubMed ID: 23961654
    [No Abstract]   [Full Text] [Related]  

  • 38. Tangible resources for preparing patients for antiviral therapy for chronic hepatitis C.
    Bonner JE; Barritt AS; Fried MW; Evon DM
    Dig Dis Sci; 2012 Jun; 57(6):1439-44. PubMed ID: 22488633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus treatment decision-making in the context of HIV co-infection: the role of medical, behavioral and mental health factors in assessing treatment readiness.
    Wagner GJ; Ryan GW
    AIDS; 2005 Oct; 19 Suppl 3():S190-8. PubMed ID: 16251817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute HCV infection.
    Grebely J; Matthews GV; Dore GJ
    Nat Rev Gastroenterol Hepatol; 2011 May; 8(5):265-74. PubMed ID: 21423258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.